HER2-targeting antibody Fc fragment FS102
Term · Oncology and biomedicine · MLC-T-ONC-014108
A proprietary, antibody fragment composed of a constant (Fc) region that is engineered to bind to the tumor-associated antigen human epidermal growth factor receptor-2 (HER2), with potential antineoplastic activity. HER2-targeted antibody Fc fragment FS102 specifically binds to its HER2 epitope, and causes downregulation of HER2-mediated signaling. This leads to tumor cell apoptosis. HER2, a member of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR) superfamily, is overexpressed on the cell surface of various solid tumors.
| Identifier | MLC-T-ONC-014108 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-HER2 FCAB FS102; Fcab FS102 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014108",
"term": "HER2-targeting antibody Fc fragment FS102",
"field": "Oncology and biomedicine",
"definition": "A proprietary, antibody fragment composed of a constant (Fc) region that is engineered to bind to the tumor-associated antigen human epidermal growth factor receptor-2 (HER2), with potential antineoplastic activity. HER2-targeted antibody Fc fragment FS102 specifically binds to its HER2 epitope, and causes downregulation of HER2-mediated signaling. This leads to tumor cell apoptosis. HER2, a member of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR) superfamily, is overexpressed on the cell surface of various solid tumors.",
"synonyms": [
"anti-HER2 FCAB FS102",
"Fcab FS102"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/her2-targeting-antibody-fc-fragment-fs102/"
}
Record 8,430 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.